Up to $835M Acquisition of Amplitude Vascular Systems Bolsters Stryker's Medtech Portfolio
SYK is trading near its 52-week low of $281 (9.5% above the low).
Summary
Stryker has announced the acquisition of Amplitude Vascular Systems (AVS) for up to $835 million. AVS developed a next-generation hydraulic intravascular lithotripsy (IVL) platform designed to treat calcified peripheral arterial disease. While Stryker's recent 10-Q (filed May 11, 2026) broadly mentioned a new acquisition, this headline provides the specific details of the target company and the transaction value, which were not previously disclosed. This strategic acquisition expands Stryker's peripheral vascular portfolio with an innovative technology, enhancing its position in the cardiovascular disease treatment market. Traders will monitor the integration of AVS's Pulse System and its potential contribution to Stryker's future revenue and earnings.
At the time of this announcement, SYK was trading at $307.70 on NYSE in the Life Sciences sector, with a market capitalization of approximately $120.1B. The 52-week trading range was $281.00 to $404.87. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.